Ekso Bionics Stock Drops 13% Despite After Company Becomes Exclusive U.S. Distributor

(RTTNews) - Ekso Bionics Holdings, Inc. (EKSO) shares fell 12.75 percent, sliding $0.5802 to $3.97 on Thursday, after the company announced it will become the exclusive U.S. sales agent and distributor for MediTouch's BalanceTutor rehabilitation system. The technology uses a patented 4D perturbation treadmill to simulate real-world balance challenges, supporting patient safety while improving rehabilitation outcomes.

Ekso Bionics is trading at $3.97 versus a previous close of $4.5502 on the Nasdaq. The stock opened at $4.25 and has traded between $3.5100 and $4.4635 so far today, with volume surging to 5.05 million shares.

The company's 52-week range is $2.73 to $14.97.